Division of Pediatric Pulmonary Medicine, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania.
Behavioral Sciences Research Institute, University of Puerto Rico, San Juan, Puerto Rico.
Ann Allergy Asthma Immunol. 2022 Apr;128(4):408-413.e2. doi: 10.1016/j.anai.2022.01.004. Epub 2022 Jan 10.
Whether persistent overweight or obesity affects lung function or asthma morbidity in youth is unclear.
To evaluate overweight or obesity that persists between school age and adolescence and change in lung function and total immunoglobulin (Ig)E and severe asthma exacerbations in Puerto Rican youth.
Prospective study of 340 Puerto Rican youth assessed at 2 visits, the first at ages 6 to 14 years and the second at ages 9 to 20 years. Persistent overweight or obesity was defined as a body mass index z-score greater than or equal to 85th percentile at both visits. Outcomes of interest were change in percent predicted (%pred) lung function measures and total IgE between study visits and severe asthma exacerbations in the year before visit 2. Logistic or linear regression was used for multivariable analysis.
In multivariable analysis, persistently overweight or obese subjects had changes in %pred forced expiratory volume in 1 second (FEV1) (β = -5.07%; 95% confidence interval, -1.51% to -8.62%; P < .01) and %pred FEV1 to forced vital capacity (FVC) ratio (β = -2.85%; 95% confidence interval, -0.18% to -5.51%; P = .04) which were lower than those observed in subjects with normal weight at both study visits (control subjects). Compared with control subjects, those who were persistently overweight or obese and those who became overweight or obese at visit 2 had increased odds of more than or equal to 1 severe asthma exacerbation in the year before visit 2. There was no significant association between persistent overweight or obesity and change in %pred FVC or total IgE (P > .20 for both instances).
In a prospective study of Puerto Rican youth, persistently overweight or obese subjects had lower changes in FEV1 or FEV1 to FVC ratio and higher odds of severe asthma exacerbations than subjects of normal weight.
持续性超重或肥胖是否会影响青少年的肺功能或哮喘发病率尚不清楚。
评估波多黎各青少年在学龄期和青春期之间持续超重或肥胖以及肺功能、总免疫球蛋白(IgE)变化和重度哮喘恶化的情况。
前瞻性研究了 340 名波多黎各青少年,他们在 2 次就诊时接受了评估,第一次就诊年龄为 6 至 14 岁,第二次就诊年龄为 9 至 20 岁。持续性超重或肥胖定义为两次就诊时的体重指数 z 评分均大于或等于第 85 百分位数。研究目的是两次就诊之间的肺功能测量的%预计值(%pred)变化和总 IgE 以及就诊前一年的重度哮喘恶化情况。使用逻辑或线性回归进行多变量分析。
在多变量分析中,持续性超重或肥胖的受试者的 1 秒用力呼气量(FEV1)%预计值(β= -5.07%;95%置信区间,-1.51%至-8.62%;P<.01)和 FEV1 与用力肺活量(FVC)比值的%预计值(β= -2.85%;95%置信区间,-0.18%至-5.51%;P=.04)变化均低于两次就诊时体重正常的受试者(对照组)。与对照组相比,持续性超重或肥胖且在就诊 2 时体重超重或肥胖的受试者,就诊前一年发生≥1 次重度哮喘恶化的几率更高。持续性超重或肥胖与 FVC 的%预计值或总 IgE 的变化之间无显著相关性(两次情况 P>.20)。
在一项针对波多黎各青少年的前瞻性研究中,持续性超重或肥胖的受试者的 FEV1 或 FEV1 与 FVC 比值变化较小,发生重度哮喘恶化的几率高于体重正常的受试者。